Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Chronic Lower Back Pain Market Grown from 2024 to 2025?
The market size for chronic lower back pain has been consistently expanding over the past few years. Projections forecast an increase from $7.72 billion in 2024 to approximately $8.08 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. Factors contributing to growth during the historic period include the rise of sedentary lifestyles, risks associated with manual labor and certain occupations, advancements in medical diagnosis, evolution in pain management techniques, and significant epidemiological research.
What Growth Rate Is Anticipated for the Chronic Lower Back Pain Market in the Coming Years?
The market size of chronic lower back pain is anticipated to significantly increase over the next few years, with a projection to reach $9.99 billion in 2029 and a compound annual growth rate (CAGR) of 5.5%. This escalation during the forecast period could be associated with the increase in non-pharmacological interventions, preventive healthcare actions, the emphasis on comprehensive treatments, advancement in regenerative medicine, and aging population patterns. Key trends during the outlook period involve attention on non-pharmacological interventions, changes in pain management techniques, awareness and education in healthcare, telemedicine along with remote surveillance, and the assimilation of regenerative medicine.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp
Who Are the Leading Companies in the Chronic Lower Back Pain Market?
Major companies operating in the chronic lower back pain market include Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.
What Are the Key Drivers of the Chronic Lower Back Pain Market?
The chronic lower back pain market is predicted to expand as a result of a rise in the number of nerve instances. These instances are described as specific events or situations where an individual demonstrates bravery, courage, or resilience when confronted with a demanding or intimidating scenario. Prolonged exposure to stress and pain may result in a phenomenon known as central sensitization, effectively making the nervous system hyper-reactive and intensifying the perception of pain even in the absence of a physical injury. For example, a UK-based weekly scientific journal, Nature, reported in July 2023 that the prevalence of peripheral neuropathy associated with nerve damage was 28.4% in adults aged 40 or older with diabetes and 11.8% in those without diabetes. Consequently, the increase in nerve instances is stimulating the expansion of the chronic lower back pain market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9946&type=smp
What Are the Key Market Segments in the Chronic Lower Back Pain Industry?
The chronic lower back pain market covered in this report is segmented –
1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain
2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain
3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users
Subsegments:
1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis
2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis
3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions
4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints
5) By Radicular Pain: Sciatica, Nerve Root Compression
6) By Muscular Pain: Muscle Strain, Muscle Spasm
7) By Other Types of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain
What Are the Latest Trends in the Chronic Lower Back Pain Market?
In the chronic lower back pain market, the key players are investing in the development of innovative pharmaceuticals to maintain their market standing and better cater to their consumers. The creation of novel drugs noticeably enhances the treatment outcomes for patients suffering from a variety of illnesses. For example, Amneal Pharmaceuticals, an American pharmaceutical entity, unveiled its baclofen oral granule, LYVISPAH (5, 10, and 20 mg) in July 2022. The U.S. Food and Drug Administration (FDA) sanctioned it for the treatment of spasticity associated with multiple sclerosis and other spinal cord disorders. LYVISPAH provides relief from flexor spasms, related pain, clones, and muscular rigidity. The drug ensures customizable dosing with single dose packages of granules in strengths of 5 mg, 10 mg and 20 mg. It is also bioequivalent to oral baclofen tablets. LYVISPAH could provide significant benefits to patients suffering from spinal cord injuries and other related diseases.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report
What Are the Key Regional Markets in the Chronic Lower Back Pain Industry?
North America was the largest region in the chronic lower back pain market in 2024. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9946
This Report Delivers Insight On:
1. How big is the chronic lower back pain market, and how is it changing globally?
2. Who are the major companies in the chronic lower back pain market, and how are they performing?
3. What are the key opportunities and risks in the chronic lower back pain market right now?
4. Which products or customer segments are growing the most in the chronic lower back pain market?
5. What factors are helping or slowing down the growth of the chronic lower back pain market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
